Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsFindings from a phase 2 trial highlighted lacosamide's effectiveness and safety in treating neonatal seizures, showing significant seizure reduction and tolerability in patients.
Here's some of what is coming soon to NeurologyLive® this week.
Ovid Therapeutics' OV329 shows promise as a safe, effective GABA-AT inhibitor for treating drug-resistant seizures, with strong phase 1 trial results.
FDA-approved RBL shows 95% success and sustained microbiome restoration in recurrent C. difficile.
5 Pulmonology Headlines You Missed in November 2025
Adjunctive Lumateperone Significantly Improves MDD Symptoms by Day 43
Stage 5 CKD May Reverse Female Survival Advantage
1.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
2.
Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control
3.
Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL
4.
Team finds broken 'brake' on cancer mutation machine.
5.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
1.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
2.
Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates
3.
Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research
4.
Future of Oncology: Targeted Therapies & Collaborative Innovation Shaping Cancer Care in the USA
5.
Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge